Clinical Trial Update: Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects [NA]

View source ↗

Summary

A clinical trial update examining how CYP2C19 genetic variants affect the pharmacokinetics of glipizide extended-release in Chinese subjects. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide Extended-Release Tablet (glipizide)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Genotype, Pharmacokinetic | NA | Status: COMPLETED